Global Thin Film Drug Manufacturing Market to Reach $21.3 Billion by 2030
The global market for Thin Film Drug Manufacturing estimated at US$11.9 Billion in the year 2022, is projected to reach a revised size of US$21.3 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2022-2030. Oral Thin Film, one of the segments analyzed in the report, is projected to record 7.5% CAGR and reach US$9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Transdermal Thin Film segment is readjusted to a revised 8.3% CAGR for the next 8-year period.The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 7.2% CAGR
The Thin Film Drug Manufacturing market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 6.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.Select Competitors (Total 47 Featured) -
- Allergan plc
- Indivior plc
- IntelGenx Corp.
- MonoSol Rx
- Novartis AG
- Pfizer, Inc.
- Solvay
- Sumitomo Dainippon Pharma Co., Ltd.
- Wolters Kluwer
- ZIM Laboratories Limited
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allergan plc
- Indivior plc
- IntelGenx Corp.
- MonoSol Rx
- Novartis AG
- Pfizer, Inc.
- Solvay
- Sumitomo Dainippon Pharma Co., Ltd.
- Wolters Kluwer
- ZIM Laboratories Limited
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 197 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 11.9 Billion |
Forecasted Market Value ( USD | $ 21.3 Billion |
Compound Annual Growth Rate | 7.5% |
Regions Covered | Global |